Pharmaceutical Industry Information Portal

HomeTagsPromomed Group

All posts by tag

Promomed Group

New product from Promomed Group for protection, ensure the functioning and repair of the nervous system cells

Promomed Group has registered a new drug Brainmax®, reaffirming its commitment to the strategy of launching innovative, knowledge-based products. The technology developed by the...

The new direct acting anticoagulant in the anticovid portfolio of Promomed Group

Promomed Group received marketing authorization certificate for a medicinal product with nadroparin calcium as active ingredient. Nadroparin is a low molecular weight heparin. It...

Russian Ministry of Health included injectable Areplivir® in the guidelines for the treatment of COVID-19

The Ministry of Health of the Russian Federation has included the injectable form of the direct-acting antiviral drug Areplivir® (favipiravir) in the updated, fourteenth, version...

Biokhimik JSC of Promomed Group and Mordovia State University agreed on further cooperation

At the meeting of the management of Biokhimik JSC with Acting Rector of the Ogarev Mordovia State University Dmitry Glushko and the scientific community...

M. Smagin: a competent system of joint planning of drugs procurements by the government and pharmaceutical business will eliminate possible shortages

In his speech at the «360 degree Pharmaceutical Supply» conference, Maxim Smagin, General Director of Promomed Group said: The domestic health care system has...

Kira Zaslavskaya: we need joint and responsible work of all participants in the pharmaceutical market

«Vision and participation are essential to address global pharmaceutical safety challenges, including the fight against the pandemic. This means that only in conditions of...
spot_img

Expert Articles

spot_img